Search

Your search keyword '"Anichini A"' showing total 211 results

Search Constraints

Start Over You searched for: Author "Anichini A" Remove constraint Author: "Anichini A" Publisher elsevier bv Remove constraint Publisher: elsevier bv
211 results on '"Anichini A"'

Search Results

2. 27P Peripheral biomarker analysis in patients with advanced urothelial carcinoma (UC) after platinum chemotherapy treated with cabozantinib (CABO) plus durvalumab (DURVA): Preliminary analysis from the phase II ARCADIA trial

3. 123P A phase II study of nivolumab (N) plus ipilimumab (I) and ASTX727 or N plus I in PD-1/PD-L1 resistant melanoma or NSCLC patients: The run-in phase of the NIBIT Foundation ML1 study

4. 26P Liquid biopsy as promising source of plasma extracellular vesicle biomarkers of response to cabozantinib (CABO) plus durvalumab (DURVA) in advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) patients (the phase II ARCADIA trial)

6. Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth

7. Treatment Intensification following Glucagon-Like Peptide-1 Receptor Agonist Treatment in Type 2 Diabetes: the RESTORE-G Real-World Study

8. SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines

9. Evaluation of coumarin-tagged deferoxamine as a Zr(IV)-based PET/fluorescence dual imaging probe

10. Immunotherapy for brain metastases and primary brain tumors

11. PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers

13. A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes

17. Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins

18. Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group

19. Adaptive plasticity of bushcricket acoustic signalling in socially heterogeneous choruses

20. PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers

22. Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit Novum

23. How long can SARS-CoV-2 persist in human corpses?

25. To compete or not to compete: bushcricket song plasticity reveals male body condition and rival distance

26. Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes)

27. Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?

28. Physicochemical properties and sorption capacities of sawdust-based biochars and commercial activated carbons towards ethoxylated alkylphenols and their phenolic metabolites in effluent wastewater from a textile district

29. Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group

30. Anticancer innovative therapy: Highlights from the ninth annual meeting

32. Hospitalization for Charcot neuroarthropathy in diabetes: A population study in Italy

33. Gender difference in diabetes related excess risk of cardiovascular events: When does the ‘risk window’ open?

34. The automatic recognition of ceramics from only one photo: The ArchAIDE app

35. Physicochemical properties and sorption capacities of sawdust-based biochars and commercial activated carbons towards ethoxylated alkylphenols and their phenolic metabolites in effluent wastewater from a textile district

37. First survival outcomes and additional secondary analyses from PURE-01: Pembrolizumab (Pembro) before radical cystectomy (RC) in muscle-invasive urothelial bladder carcinoma (MIBC)

38. Comparison between four tropical wood species for their resistance to marine borers (Teredo spp and Limnoria spp) in the Strait of Messina

39. Gender difference in diabetes-associated risk of first-ever and recurrent ischemic stroke

40. The role of joint mobility in evaluating and monitoring the risk of diabetic foot ulcer

41. New technologies for plant food processing in the Gravettian

42. Endoscopic extradural anterior clinoidectomy and optic nerve decompression through a pterional port

44. MA04.06 PD-1 Blockade Promotes Hyperprogressive Disease in NSCLC Through Macrophages Activation via Antibody-Fc/FcR Interaction

45. Comprehensive biomarker analyses and updated results of PURE-01 study: Neoadjuvant pembrolizumab (pembro) in muscle-invasive urothelial bladder carcinoma (MIBC)

50. Pembrolizumab as Neoadjuvant Therapy Preceding Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Group, Phase 2 Study

Catalog

Books, media, physical & digital resources